-

Operator Strategies for IoT Connectivity: Value-Added Features and Services are Key - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Operator Strategies for IoT Connectivity: Value-Added Features and Services" report has been added to ResearchAndMarkets.com's offering.

Operators have no choice but to review their IoT connectivity offers and develop new features and propositions if they are to remain competitive and develop higher-value services.

Operators cannot easily differentiate their IoT connectivity propositions. Most features are replicable and enterprises are not typically willing to pay for them. Nevertheless, operators should innovate in order to add new features and services and to ensure that they remain competitive and meet enterprise requirements. In this report, the analyst analyses some of the more innovative operator approaches to delivering IoT connectivity.

Operators are introducing new SIM and software features to enhance their connectivity offers and are developing targeted propositions to address vertical-specific needs. Not all of these initiatives will generate significant new revenue, but they may enable operators to position their IoT services as premium connectivity services.

This report provides:

  • analysis of the different approaches that operators have adopted to build and defend the value of their IoT connectivity offers
  • examples of operators' initiatives to differentiate their IoT connectivity offers
  • information and insights that operators can consider using to differentiate their IoT connectivity offers.

For more information about this report visit https://www.researchandmarkets.com/r/oxui13

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

Trends Shaping the $5 Billion Spasticity Treatment Market, 2026-2034: Focus on Multimodal Care and Treatment Innovations - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Spasticity Treatment Market Outlook 2026-2034: Market Share, and Growth Analysis" has been added to ResearchAndMarkets.com's offering. The global Spasticity Treatment Market, valued at USD 5.02 billion in 2025, is set to expand at a CAGR of 5.5%, reaching USD 8.13 billion by 2034. This growth is driven by innovations in pharmacologic therapies, interventional procedures, and multimodal rehabilitative modalities designed to manage spasticity associated with various...

Intracranial Aneurysm Market and Competition Outlook 2026-2034: Market Share, Growth Analysis, Strategic Initiatives and Emerging Trends - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Intracranial Aneurysm Market Outlook 2026-2034: Market Share, and Growth Analysis" has been added to ResearchAndMarkets.com's offering. The Intracranial Aneurysm Market, valued at USD 1.79 billion in 2025, is forecasted to grow at a CAGR of 10% to reach USD 4.22 billion by 2034. Trends indicate enhanced demand for low-profile flow diverters, resheathable delivery systems, and AI-assisted aneurysm detection, propelled by the global incidence of subarachnoid hemorrha...

Insomnia Drugs Market Outlook 2026-2034: Trends, Shares, and Growth Analysis Featuring Merck & Co., Eisai Co., Viatris, Perrigo Co., Neurim Pharmaceuticals and More - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Insomnia Drug Market Outlook 2026-2034: Market Share, and Growth Analysis" has been added to ResearchAndMarkets.com's offering. The Insomnia Drug Market is projected to expand from USD 2.95 billion in 2025 to USD 4.62 billion by 2034, exhibiting a CAGR of 5.1%. Encompassing both prescription and OTC solutions, the market spans across various formulations designed to alleviate sleep-onset and sleep-maintenance issues. Key pharmacologic categories include non-benzodi...
Back to Newsroom